NYXOAH SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.6 EUR | +2.78% |
|
+4.35% | +125.35% |
| 12/04 | Nyxoah Names New Chief Medical Officer | MT |
| 12/04 | Nyxoah S.A. Appoints Maurits Boon as Chief Medical Officer | CI |
Chart calendar Nyxoah SA
d7e8739.Bm7yw90K_KZwAH0Y2miBrDqoSY0GxjQvJHpEpjGMCCE.YQamu7dOxMczbC1ckADTyQjELe9In2FlcQs10VX0WlI0W5mi6E6t3zttJA~71a5dbf06e970d7c77a0ab4d370c9e93
Upcoming events on Nyxoah SA
Past events on Nyxoah SA
| 20/03/2024 02:00 am | DREAM U.S. Pivotal Study Results Call |
| 12/03/2024 08:10 pm | Oppenheimer Healthcare MedTech & Services Conference |
| 06/03/2024 03:00 am | Q4 2023 Earnings Call |
| 06/03/2024 02:35 am | Q4 2023 Earnings Release |
| 30/11/2023 01:00 am | Piper Sandler Healthcare Conference |
| 15/11/2023 10:30 pm | Jefferies London Healthcare Conference |
| 09/11/2023 03:00 am | Q3 2023 Earnings Call |
| 09/11/2023 02:35 am | Q3 2023 Earnings Release |
| 27/09/2023 07:15 pm | Cantor Fitgerald Global Healthcare Conference |
| 13/09/2023 09:45 pm | Baird Global Healthcare Conference |
| 12/09/2023 11:00 pm | H.C. Wainwright Global Investment Conference |
| 09/08/2023 07:00 pm | Canaccord Genuity Growth Conference |
| 09/08/2023 02:00 am | Q2 2023 Earnings Call |
| 09/08/2023 01:35 am | Q2 2023 Earnings Release |
| 14/06/2023 05:30 pm | Annual General Meeting |
| 17/05/2023 02:00 am | Q1 2023 Earnings Call |
| 17/05/2023 01:35 am | Q1 2023 Earnings Release |
| 24/03/2023 01:30 am | Investor & Analyst Meeting - Key Opinion Leaders |
| 23/03/2023 02:00 am | Q4 2022 Earnings Call |
| 23/03/2023 01:35 am | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 | 0,07 0,50 -86.2% | 0,85 1,70 -49.85% | 3,08 4,77 -35.29% | 4,35 4,30 1.14% | 8,78 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -31,4 -32,0 1.94% | -42,7 -43,7 2.26% | -68,7 |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | -11,2 -9,80 -14.53% | -26,2 -24,7 -6.26% | -32,5 -31,7 -2.5% | -45,1 -45,8 1.44% | -59,5 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -30,1 -26,3 -14.49% | -44,7 -44,5 -0.37% | -60,5 |
|
Net income Million EUR | Released Forecast Spread | -7,26 | 0,00 0,00 - | 0,00 0,00 - | -31,2 -26,6 -17.24% | -43,2 -43,5 0.69% | -61,0 |
|
EPS EUR | Released Forecast Spread | -0,49 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -1,55 -1,57 1.59% | -2,11 |
| Announcement Date | 08/09/20 | 09/04/21 | 24/03/22 | 22/03/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 S1 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,36 0,50 -29% | 0,25 0,82 -69.51% | 0,50 1,42 -64.9% | 0,66 0,47 40.95% | 0,94 1,04 -10.11% | 0,18 1,40 -86.98% | 1,31 2,97 -55.92% | 0,44 1,21 -63.57% | 1,11 1,09 1.75% | 0,98 1,38 -29.2% | 1,82 1,80 1.41% | 1,21 | 1,93 | 2,15 | 3,41 | 6,45 |
|
EBITDA Million EUR | Released Forecast Spread | -10,7 -11,1 3.37% | -6,93 -8,40 17.5% | -8,36 -9,60 12.88% | -8,76 -9,30 5.77% | -11,1 -11,0 -1.3% | -10,5 -10,9 4.07% | -10,1 -8,05 -25.71% | -12,3 | -18,2 | -17,8 | -27,8 | |||||
|
EBIT Million EUR | Released Forecast Spread | -11,5 -11,7 1.44% | -7,31 -6,53 -11.96% | -14,6 -14,3 -1.95% | -7,28 -8,50 14.35% | -7,39 -8,12 9.02% | -8,78 -8,29 -5.88% | -9,05 -8,12 -11.47% | -11,4 -8,87 -28.45% | -11,9 -11,2 -6.42% | -11,0 -12,2 9.98% | -10,8 -11,3 4.32% | -12,1 | -14,1 | -15,0 | -18,3 | -7,87 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -12,5 -8,70 -43.73% | -11,7 -9,07 -29.28% | -11,9 -11,5 -3.35% | -9,84 -12,3 19.68% | -11,2 -11,1 -1.43% | -12,4 | -14,4 | -15,2 | -18,5 | -7,87 | ||||||
|
Net income Million EUR | Released Forecast Spread | -13,3 -8,70 -52.81% | -11,9 -9,08 -31.2% | -12,8 -11,5 -10.87% | -7,61 -12,4 38.83% | -10,9 -10,4 -5.11% | -12,5 | -14,5 | -15,3 | -18,7 | -7,87 | ||||||
|
EPS EUR | Released Forecast Spread | -0,45 -0,42 -6.43% | -0,27 -0,40 33.5% | -0,38 -0,26 -45.77% | -0,46 | -0,67 | -0,65 | -0,63 | -0,58 | ||||||||
| Announcement Date | 31/08/21 | 24/03/22 | 24/03/22 | 09/05/22 | 08/08/22 | 08/11/22 | 22/03/23 | 16/05/23 | 08/08/23 | 08/11/23 | 05/03/24 | - | - | - | - | - |
| 29/04/2024 10:30 am | PHILIPS NV: Q1 2024 Earnings Release |
| 29/04/2024 03:30 pm | REVVITY, INC.: Q1 2024 Earnings Release |
| 30/04/2024 03:50 pm | GE HEALTHCARE TECHNOLOGIES INC.: Q1 2024 Earnings Release |
| 01/05/2024 01:35 am | TRANSMEDICS GROUP, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | INMODE LTD.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BRUKER CORPORATION: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | HOLOGIC, INC.: Q2 2024 Earnings Release |
| 03/05/2024 01:35 am | LEMAITRE VASCULAR, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | ILLUMINA, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | QUANTERIX CORPORATION: Q1 2024 Earnings Release (Projected) |
Past sector events for Nyxoah SA
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NYXH Stock
- Calendar Nyxoah SA
